Number | Year | Status | Diseases Area | Type | Achievements |
1 | 2009 | Completed | Diabetes | T2DM | UK Top recruiting Site |
2 | 2010 | Completed | Diabetes | T2DM | Global lead Feb, Mar and Apr 2010. Taret of 10 subjects, recruited within 14 days. All 10 particpants randomised |
3 | 2010 | Completed | Diabetes | T2DM | First patient consented to take part 26/5/10 day after R&D Approval |
4 | 2010 | Completed | Diabetes | T2DM | Recruitment Target of 5, 8 Screened, 7 Randomised. UK Only study. Tayside was the joint top recruitment site wuth 36 sites involved. |
5 | 2010 | Ongoing | Cardiovascular | DAPT Interventional Study | UK Top Recruiter and EU First Subject In. |
6 | 2010 | Ongoing | Cardiovascular | Heart Failure | Global First Subject In |
7 | 2010 | Completed | Diabetes | T2DM | Global First Subject In |
8 | 2010 | Completed | Oncology | Metastatic Breast Cancer | Global First Subject In |
9 | 2010 | Ongoing | Diabetes | T2DM CV Outcomes | Global First Subject In |
10 | 2010 | Completed | Oncology | Neuropathic Pain | UK first subject in and first UK site to complete at target |
11 | 2010 | Ongoing | Cardiovascular | Atrial Fibrillation | EU First Subject In |
12 | 2011 | Ongoing | Ageing & Health | Interventional Nutritional Supplement | Recruitment Target of 25 subjects delivered in 12 weeks |
13 | 2011 | Ongoing | Cardiovascular | Heart Failure | UK First Patient |
